Growth Metrics

China Pharma Holdings (CPHI) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to $42392.0.

  • China Pharma Holdings' Exchange Rate Effect rose 31386.31% to $42392.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$66842.0, marking a year-over-year decrease of 23798.07%. This contributed to the annual value of -$66232.0 for FY2024, which is 30746.12% down from last year.
  • According to the latest figures from Q3 2025, China Pharma Holdings' Exchange Rate Effect is $42392.0, which was up 31386.31% from -$39627.0 recorded in Q2 2025.
  • Over the past 5 years, China Pharma Holdings' Exchange Rate Effect peaked at $50439.0 during Q4 2023, and registered a low of -$153626.0 during Q3 2022.
  • Over the past 5 years, China Pharma Holdings' median Exchange Rate Effect value was -$4092.0 (recorded in 2021), while the average stood at -$15417.1.
  • The largest annual percentage gain for China Pharma Holdings' Exchange Rate Effect in the last 5 years was 128371.65% (2022), contrasted with its biggest fall of 365430.11% (2022).
  • Quarter analysis of 5 years shows China Pharma Holdings' Exchange Rate Effect stood at -$14578.0 in 2021, then soared by 126.57% to $3874.0 in 2022, then surged by 1201.99% to $50439.0 in 2023, then tumbled by 227.35% to -$64236.0 in 2024, then soared by 165.99% to $42392.0 in 2025.
  • Its Exchange Rate Effect stands at $42392.0 for Q3 2025, versus -$39627.0 for Q2 2025 and -$5371.0 for Q1 2025.